CTOs on the Move

SelectCare of Texas

www.sctexas.com

 
SelectCare of Texas is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.sctexas.com
  • 4888 Loop Central Dr Ste 700
    Houston, TX USA 77081
  • Phone: 713.843.6725

Executives

Name Title Contact Details

Similar Companies

Eden Organix

Eden Organix is a Highland Park, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Parkview Imaging Open M R I

Parkview Imaging Open M R I is a Santa Monica, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prairie North Health Region

Prairie North Health Region is a North Battleford, SK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St Rose Hospital

St Rose Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. St Rose Hospital is based in Hayward, CA. You can find more information on St Rose Hospital at www.strosehospital.org

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.